S.Y. Amy Cheung, PhD

S.Y. Amy Cheung, PhD, is a Vice President at Certara, regional lead (EU and APAC) for Quantitative Science Services within Certara Drug Development Services, and Global Lead of the Pediatric and Maternal Health Center of Excellence/Innovation Engines. Dr. Cheung has more than 20 years of experience in modeling and simulation, as well as clinical pharmacology, with expertise in PBPK/PD mechanistic modelling, special populations (e.g., pediatrics, maternal, and geriatrics), extrapolation, model-based meta-analysis, vaccines, infections, HIV, complex biologics, and different therapeutic areas across early to late-phase drug development. She is currently an honorary professor in the School of Engineering at the University of Warwick, UK. She is leading an EU funding project, ERAMET (grant agreement number 101137141), in work package 5, championing the enhancement and utilisation of extrapolation in the pediatric population and for rare diseases.

Before joining Certara, she was a Senior Pharmacometrician and Scientific and Project Leader at the AZ Pediatric Working Group, which included 22+ cross-functional pediatric experts. During this time, she also served as the company representative on the IMI DDMoRe initiative and co-led work packages (e.g., PMX-workflow, cardiovascular training). Dr. Cheung has been a member of the EFPIA MID3 workgroup since the 2011 EMA M&S workshop, which resulted in several white papers. Currently, she is contributing her expertise to various professional societies, such as the IQ Consortium, EFPIA, EFGCP, ASCPT, and EU Horizon-funded projects. She has published over 50 papers on MIDD methodology/applications, reviews, and white papers in peer-reviewed journals.